Jorey Chernett Reports 18.5% Stake in Kazia Therapeutics Ltd (KZIA)

On May 27, 2026, Jorey Chernett filed a Schedule 13G/A with the SEC, reporting a significant ownership stake in Kazia Therapeutics Ltd (KZIA). As of the event date on May 26, 2026, Chernett beneficially owns 2,114,649 American Depositary Shares (ADS), representing 18.5% of the company's outstanding shares. This filing marks an increase from a previously reported 0.0% position, indicating a substantial new investment or a corrected reporting of holdings. The shares are held with sole voting and dispositive power. The calculation of the ownership percentage is based on 11,426,899 ADS outstanding as of March 12, 2026. Chernett, a U.S. citizen based in Michigan, certified that the securities were not acquired for the purpose of changing or influencing the control of the issuer. This Amendment No. 3 to the Schedule 13G highlights a major concentrated position by an individual investor in the Sydney-based pharmaceutical company.